Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension and the kidney.

Michael Wiederkehr1, Robert Toto, Andrew Z Fenves

  • 1Dallas Nephrology Associates, Dallas, Texas 75204-6225, USA. wiederkehrm@dneph.com

Seminars in Nephrology
|October 6, 2005
PubMed
Summary

Hypertension and diabetes are major causes of chronic kidney disease (CKD). Aggressively managing blood pressure and blood sugar is crucial for preventing kidney disease progression and its severe outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urea vs. tolvaptan for hospitalized patients with SIADH.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same author

Phosphate homeostasis and apparent treatment-resistant hypertension in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Obesity-Related Hypertension: An Emerging Clinical Phenotype.

The American journal of cardiology·2026
Same author

Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis.

Current heart failure reports·2026
Same author

The modifiers that cause changes in gene essentiality.

Cell systems·2026

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Hypertension is a primary risk factor for chronic kidney disease (CKD), potentially leading to end-stage renal disease.
  • Diabetes mellitus is the leading cause of end-stage renal disease in Western countries.
  • Both hypertension and diabetes contribute significantly to CKD development and its complications.

Purpose of the Study:

  • To review the pathophysiologic mechanisms linking hypertension and kidney disease.
  • To discuss therapeutic strategies for managing hypertension in the context of renal insufficiency.
  • To highlight the importance of early microalbuminuria detection and management.

Main Methods:

  • Review of existing literature on hypertension, diabetes, and chronic kidney disease.
  • Analysis of pathophysiologic pathways involved in renal damage.
  • Evaluation of therapeutic interventions, including renin-angiotensin system blockade.

Main Results:

  • Effective hypertension control is a proven method for preventing renal disease.
  • Reducing systemic and intraglomerular pressure is key in managing renal insufficiency.
  • Renin-angiotensin system inhibitors offer specific renal and cardiovascular benefits.

Conclusions:

  • Aggressive control of hypertension and diabetes is essential for reducing CKD risk.
  • Targeted therapies, such as renin-angiotensin system blockers, are vital for kidney protection.
  • Early detection and treatment of microalbuminuria are integral to managing hypertensive kidney disease.

Related Experiment Videos